Navigation Links
Varian Medical Systems Schedules Third Quarter FY2009 News Release and Conference Call
Date:6/23/2009

PALO ALTO, Calif., June 23 /PRNewswire-FirstCall/ -- Varian Medical Systems (NYSE: VAR) announced today that it will report results for third quarter of fiscal year 2009 following the close of regular trading on Wednesday, July 29, 2009. The news release will be followed by a teleconference available to all interested parties at 2:00 p.m. PT. The news release and information on the conference call webcast will be available on the company website at: www.varian.com/investor. Details on the conference call and replay follow:

    Teleconference:  Telephone from within the U.S.:

                     -- Dial 1-800-260-8140 and enter access code 31906727
                        prior to the call at 2:00 p.m.PT/5:00 p.m. ET.
                     Telephone from outside the U.S.:
                     -- Dial 1-617-614-3672 and enter access code 31906727
                        prior to the call at 2:00 p.m. PT/5:00 p.m. ET.
                     *Note: If the number of lines allocated to the call is
                     exhausted, the webcast or replay should be utilized.

    Replay:          The teleconference will be rebroadcast until 8:00 p.m.
                     ET, Friday, July 31, 2009 and can be accessed by phone
                     or Web link as follows:
                     -- Telephone from within the U.S.: Dial 1-888-286-8010 
                        and enter access code 35168740.
                     -- Telephone from outside the U.S.: Dial 1-617-801-6888
                        and enter access code 35168740.
                     -- Internet: Click on the "Quarterly Conference Call"
                        icon on the company's investor relations website at
                        www.varian.com/investor
                     -- Web conferences will be archived on the company
                        website for a year.

For automatic "e-mail alerts" regarding Varian news and events, investors can subscribe on the company website: http://varian.investorroom.com/index.php?s=58.

For additional information contact Birgit Myles at 650-424-6637 or birgit.myles@varian.com.

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,100 people who are located at manufacturing sites in North America and Europe and in its 79 offices and facilities around the world. For more information, visit http://www.varian.com/.

    FOR INFORMATION CONTACT:
    Spencer Sias, (650) 424-5782
    Vice President, Corporate Communications
    and Investor Relations
    spencer.sias@varian.com


'/>"/>
SOURCE Varian Medical Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Varians RapidArc Radiotherapy Technology Enables Pioneering Cancer Treatments at Top Dutch Oncology Center
2. Leading Healthcare Group Selects Varian Medical Systems to Supply Cancer Treatment Technology for Treatment Centers Across the Western United States
3. Ovarian Cancer Breakthrough Heralds New Era of Treatment
4. Access Pharmaceuticals Provides Update on ProLindac(TM) Phase 2 Ovarian Cancer Trial and Clinical Development Plan
5. Telik Presents Results at ASCO From ASSIST-5 Trial of TELCYTA in Platinum Refractory and Resistant Ovarian Cancer
6. New Insights, Inroads Against Breast, Ovarian Cancers
7. New Fast and Precise Treatment Planning System Among Varian Medical Systems Highlights at American Brachytherapy Society 2009 Meeting
8. Dream team targets key driver for breast, ovarian, endometrial cancers
9. Varian Medical Systems Introduces the PaxScan 3030+ X-Ray Image Detector for Interventional Angiography
10. Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia and Ovarian Cancer Will Be Presented at ASCO
11. The Diagnosis Every Woman Dreads - Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
(Date:6/24/2016)... ... 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida ... their peers for this recognition are considered among the top 2 percent of lawyers ... as members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark ...
(Date:6/24/2016)... ... ... Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair ... hour by 2020 and then adjusting it yearly to increase at the same rate as ... the wage floor does not erode again, and make future increases more predictable. , The ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research ... MEMS Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data ... analysis. Assessment of major trends with potential impact on the ... analysis of market segmentation which comprises of sub markets, regional ...
(Date:6/23/2016)... 23, 2016 Bracket , a leading clinical ... generation clinical outcomes platform, Bracket eCOA (SM) 6.0, at ... 26 – 30, 2016 in Philadelphia , ... Outcome Assessment product of its kind to fully integrate with ... Bracket eCOA 6.0 is a flexible platform for electronic clinical ...
(Date:6/23/2016)... -- Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in ... . ... ... ... Astellas is ...
Breaking Medicine Technology: